Goldstein, Jacqueline I.
Fredrik Jarskog, L.
Hilliard, Chris
Alfirevic, Ana
Duncan, Laramie
Fourches, Denis
Huang, Hailiang
Lek, Monkol
Neale, Benjamin M.
Ripke, Stephan
Shianna, Kevin
Szatkiewicz, Jin P.
Tropsha, Alexander
van den Oord, Edwin JCG
Cascorbi, Ingolf
Dettling, Michael
Gazit, Ephraim
Goff, Donald C.
Holden, Arthur L.
Kelly, Deanna L.
Malhotra, Anil K.
Nielsen, Jimmi
Pirmohamed, Munir
Rujescu, Dan
Werge, Thomas
Levy, Deborah L.
Josiassen, Richard C.
Kennedy, James L.
Lieberman, Jeffrey A.
Daly, Mark J.
Sullivan, Patrick F.
Article History
Received: 2 April 2014
Accepted: 18 July 2014
First Online: 4 September 2014
Competing interests
: L.F.J. has received grant support from Genentech, Amgen, and Sunovion in the past 3 years, and is a member of a Data Monitoring Committee for Janssen. A.H. is an employee of iSAEC, a 501(c)(3) non-profit research organization. J.A.L. serves on the Advisory Board of EnVivo and Intracellular Therapies and does not receive direct financial compensation or salary support for his participation. He receives grant support from Biomarin, EnVivo, Genentech, Novartis, Psychogenics and Sunovion; is a member of the Advisory Board of Pear Therapeutics and holds a financial interest; and holds a patent from Repligen. The remaining authors declare no competing financial interests.